SCHEMBL4566709

SCHEMBL4566709

CCc1cc(-c2ccc(-c3cc(CCC(=O)O)n[nH]3)cc2)ccc1OOC

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 2/20 0.37
LTB4R Q15722 7/20 0.37
SRD5A2 P31213 1/20 0.36
NPY5R Q15761 1/20 0.36
TNIK Q9UKE5 4/20 0.35
CSNK2A2 P19784 1/20 0.34
CSNK2A1 P68400 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
PKM P14618 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34
LTB4R2 Q9NPC1 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4092430 0.80 NR1H4 (0.61) NR1H4LTB4RSRD5A2MEN1LMNA
SCHEMBL4102391 0.71 NR1H4 (0.60) NR1H4LTB4RSRD5A2MEN1LMNA
SCHEMBL3333875 0.70 NR1H4 (0.46) NR1H4NPY5RTNIK
SCHEMBL4089846 0.69 MAPT (0.38) MEN1LMNAMAPK1KMT2A
SCHEMBL7379027 0.65 CYP1A2 (0.50)
SCHEMBL4085995 0.64 SMN1; SMN2 (0.54) SRD5A2MEN1LMNAKMT2A
SCHEMBL4097796 0.63 ALPL (0.64) MEN1LMNAKMT2A
SCHEMBL855024 0.62 HCAR2 (0.48) NR1H4
SCHEMBL10271521 0.62 RAB9A (0.63) NPY5RTNIKCSNK2A2CSNK2A1MEN1
SCHEMBL12298063 0.61 RAB9A (0.55) TNIKMEN1LMNAPKMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013176-A2 DIARYL COMPOUNDS AS NON-STEROIDAL INHIBITORS OF 17-BETA HYDROXYSTEROID DEHYDROGENASE AND/OR STEROID SULPHATASE FOR THE TREATMENT OF OESTROGEN-RELATED DISEASES SUCH AS HORMONE DEPENDENT BREAST CANCER Sterix Limited (GB) 2009-01-14 EP disclosed
WO-2007096647-A2 DIARYL COMPOUNDS AS NON-STEROIDAL INHIBITORS OF 17-BETA HYDROXYSTEROID DEHYDROGENASE AND/OR STEROID SULPHATASE FOR THE TREATMENT OF OESTROGEN-RELATED DISEASES SUCH AS HORMONE DEPENDENT BREAST CANCER STERIX LIMITED (GB) 2007-08-30 WO disclosed